Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1992 1
1999 1
2005 2
2006 1
2007 3
2008 3
2009 9
2010 9
2011 9
2012 7
2013 5
2014 6
2015 4
2016 2
2017 8
2018 14
2019 16
2020 11
2021 10
2022 7
2023 12
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for P. kirova
Your search for P. Kšírová retrieved no results
Involved Site Radiation Therapy in Adult Lymphomas: An Overview of International Lymphoma Radiation Oncology Group Guidelines.
Wirth A, Mikhaeel NG, Aleman BMP, Pinnix CC, Constine LS, Ricardi U, Illidge TM, Eich HT, Hoppe BS, Dabaja B, Ng AK, Kirova Y, Berthelsen AK, Dieckmann K, Yahalom J, Specht L. Wirth A, et al. Int J Radiat Oncol Biol Phys. 2020 Aug 1;107(5):909-933. doi: 10.1016/j.ijrobp.2020.03.019. Epub 2020 Apr 7. Int J Radiat Oncol Biol Phys. 2020. PMID: 32272184 Free article. Review.
Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial.
Bartelink H, Maingon P, Poortmans P, Weltens C, Fourquet A, Jager J, Schinagl D, Oei B, Rodenhuis C, Horiot JC, Struikmans H, Van Limbergen E, Kirova Y, Elkhuizen P, Bongartz R, Miralbell R, Morgan D, Dubois JB, Remouchamps V, Mirimanoff RO, Collette S, Collette L; European Organisation for Research and Treatment of Cancer Radiation Oncology and Breast Cancer Groups. Bartelink H, et al. Lancet Oncol. 2015 Jan;16(1):47-56. doi: 10.1016/S1470-2045(14)71156-8. Epub 2014 Dec 9. Lancet Oncol. 2015. PMID: 25500422 Clinical Trial.
Median follow-up was 17.2 years (IQR 13.0-19.0). 20-year overall survival was 59.7% (99% CI 56.3-63.0) in the boost group versus 61.1% (57.6-64.3) in the no boost group, hazard ratio (HR) 1.05 (99% CI 0.92-1.19, p=0.323). Ipsilateral breast tumour recurrence was the first …
Median follow-up was 17.2 years (IQR 13.0-19.0). 20-year overall survival was 59.7% (99% CI 56.3-63.0) in the boost group versus 61.1% (57.6 …
Qualitative indicators of milk of Simmental and Holstein cows in different seasons of lactation.
Khastayeva AZ, Zhamurova VS, Mamayeva LA, Kozhabergenov AT, Karimov NZ, Muratbekova KM. Khastayeva AZ, et al. Vet World. 2021 Apr;14(4):956-963. doi: 10.14202/vetworld.2021.956-963. Epub 2021 Apr 21. Vet World. 2021. PMID: 34083946 Free PMC article.
MATERIALS AND METHODS: In total, 80 milk samples (40 Simmental and 40 Holstein) were analyzed from LLP "Kirova" of Pavlodar region (Simmental breed) and JSC "Astana-Onim" of Akmola region (Holstein breed) in the Republic of Kazakhstan. ...RESULTS: The Simmental cows had th …
MATERIALS AND METHODS: In total, 80 milk samples (40 Simmental and 40 Holstein) were analyzed from LLP "Kirova" of Pavlodar region (S …
Pediatric Plasma Cell Neoplasms: A Population-Based Study.
Loap P, Vignon M, Bouscary D, Kirova Y. Loap P, et al. Clin Lymphoma Myeloma Leuk. 2022 Nov;22(11):841-846. doi: 10.1016/j.clml.2022.07.003. Epub 2022 Jul 11. Clin Lymphoma Myeloma Leuk. 2022. PMID: 35941071

Hispanic patients represented 50% of the pediatric plasma cell neoplasm cases (but only 11.1% of adult cases, P < .01). Female-to-Male ratio was 1.36. Five-year overall survival rates were 88.2% (95% confidence interval [95% CI]: 74.2%-100%) for pediatric plasmacytoma a

Hispanic patients represented 50% of the pediatric plasma cell neoplasm cases (but only 11.1% of adult cases, P < .01). Female-to-

Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature.
Kirova YM, Savignoni A, Sigal-Zafrani B, de La Rochefordiere A, Salmon RJ, This P, Asselain B, Stoppa-Lyonnet D, Fourquet A. Kirova YM, et al. Breast Cancer Res Treat. 2010 Feb;120(1):119-26. doi: 10.1007/s10549-009-0685-6. Epub 2009 Dec 24. Breast Cancer Res Treat. 2010. PMID: 20033769 Review.

Tumours in mutation carriers were more likely to be grade III (P < 10(-4)) and oestrogen receptor negative (P = 0.005) than in non-carriers and controls. ...There was no significant difference in ipsilateral tumours between mutation carriers, non-carriers and con

Tumours in mutation carriers were more likely to be grade III (P < 10(-4)) and oestrogen receptor negative (P = 0.005) than

Pelvic insufficiency fracture (PIF) incidence in patients treated with intensity-modulated radiation therapy (IMRT) for gynaecological or anal cancer: single-institution experience and review of the literature.
Bazire L, Xu H, Foy JP, Amessis M, Malhaire C, Cao K, De La Rochefordiere A, Kirova YM. Bazire L, et al. Br J Radiol. 2017 May;90(1073):20160885. doi: 10.1259/bjr.20160885. Epub 2017 Mar 14. Br J Radiol. 2017. PMID: 28291401 Free PMC article. Review.
Age and menopausal status were correlated with an increased fracture risk (p = 0.0274 and p < 0.0001, respectively). The site of the primary tumour (gynaecological or anal canal) was not associated with an excess fracture risk. ...

Age and menopausal status were correlated with an increased fracture risk (p = 0.0274 and p < 0.0001, respectively). The si

Tumor-infiltrating lymphocytes are associated with poor prognosis in invasive lobular breast carcinoma.
Tille JC, Vieira AF, Saint-Martin C, Djerroudi L, Furhmann L, Bidard FC, Kirova Y, Tardivon A, Reyal F, Carton M, Vincent-Salomon A. Tille JC, et al. Mod Pathol. 2020 Nov;33(11):2198-2207. doi: 10.1038/s41379-020-0561-9. Epub 2020 May 13. Mod Pathol. 2020. PMID: 32404955 Free article.
Similar results were observed for iDFS (p = 0.004 for Cox univariate and p = 0.005 for log-rank test). ...Prominent nucleoli was the only nuclear feature associated with poor OS (p = 0.05) and iDFS (p = 0.05) in univariate Cox survival analysis. ...
Similar results were observed for iDFS (p = 0.004 for Cox univariate and p = 0.005 for log-rank test). ...Prominent nucleoli w …
Recognition of unprovoked (idiopathic) pulmonary embolism-Prospective observational study.
Stoeva N, Kirova G, Staneva M, Lekova D, Penev A, Bakalova R. Stoeva N, et al. Respir Med. 2018 Feb;135:57-61. doi: 10.1016/j.rmed.2018.01.001. Epub 2018 Jan 17. Respir Med. 2018. PMID: 29414454 Free article.

The patients in the unprovoked PE-group were younger compared to provoked PE-group (56.67 17.95 vs 63.76 14.58, p < .0001) and the males predominated vs females (62.04% vs 37.96%, p = .012). ...One-month mortality was lower in unprovoked PE-group than in provoked

The patients in the unprovoked PE-group were younger compared to provoked PE-group (56.67 17.95 vs 63.76 14.58, p < .0001) and the

122 results